ACTRN12618001121257	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12619000769189	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT02477826	*NOT prior_therapy:systemic_therapy
NCT02609776	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT02775435	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03358875	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT03468426	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT03497767	*NOT prior_therapy:immune_checkpoint_blockade
NCT03516981	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03539536	*NOT prior_therapy:immune_checkpoint_blockade
NCT03625323	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT03735121	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT03948763	*NOT prior_therapy:Pembrolizumab
NCT03976375	*NOT prior_therapy:Pembrolizumab
NCT03994393	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04035486	*NOT prior_therapy:systemic_therapy
NCT04129502	*NOT prior_therapy:systemic_therapy
NCT04154956	*NOT prior_therapy:Docetaxel
NCT04194944	*NOT prior_therapy:Pembrolizumab
NCT04222972	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04248829	*NOT prior_therapy:systemic_therapy
NCT04294810	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04432207	*NOT prior_therapy:immune_checkpoint_blockade
NCT04434482	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04447118	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04475939	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04487080	*NOT prior_therapy:systemic_therapy
NCT04513925	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04585815	*NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04619004	*NOT prior_therapy:Bevacizumab
NCT04623775	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04624204	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04644237	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04655976	*NOT prior_therapy:Docetaxel
NCT04656652	*NOT prior_therapy:Docetaxel
NCT04702880	*NOT prior_therapy:systemic_therapy
NCT04725188	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04745689	*NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04746924	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04914897	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04921358	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
